<p class="MsoNormal">Abu Dhabi-based healthcare provider, Mubadala Healthcare, will partly fund a UK drug trial that aims to help diabetic patients with COVID-19 overcome the effects of the virus. The amount pledged by Mubadala is as yet undisclosed, but it will help fast-track research on the new drug.</p><p class="MsoNormal"></p>
